Page 2 of 2 FirstFirst 12
Results 11 to 20 of 20

Thread: Miscellaneous

  1. #11


    The state of AI in pharma

    May 13, 2020

    A tumultuous first quarter to say the least, but what does it mean for your AI initiatives? Are hospitals and pharmaceutical companies spending less energy pushing their AI initiatives forward? Or is AI and automation more important than ever in this time of economic uncertainty?

    PANELISTS:
    - Subroto Mukherjee, Senior Manager and Head of Innovation and Emerging Technology, Americas, GlaxoSmithKline Consumer Healthcare
    - Sandeep Burugupalli, Senior Director, Global Medical Epidemiology, Data Center of Excellence, Pfizer [Moderator]
    - Tatiana Sorokina, Solutions Director, Data Science & Artificial Intelligence, Novartis
    - Eric Maloney, Director of Strategy – Advisory Partners, Blue Prism
    - Abhijit Chakraverty, Managing Director, Deloitte Consulting

  2. #12


    Robert Langer: Edison of Medicine | AI Podcast #105 with Lex Fridman

    Jun 30, 2020

    Robert Langer is a professor at MIT and one of the most cited researchers in history, specializing in biotechnology fields of drug delivery systems and tissue engineering. He has bridged theory and practice by being a key member and driving force in launching many successful biotech companies out of MIT. This conversation is part of the Artificial Intelligence podcast.

    Outline:
    0:00 - Introduction
    3:07 - Magic and science
    5:34 - Memorable rejection
    8:35 - How to come up with big ideas in science
    13:27 - How to make a new drug
    22:38 - Drug delivery
    28:22 - Tissue engineering
    35:22 - Beautiful idea in bioengineering
    38:16 - Patenting process
    42:21 - What does it take to build a successful startup?
    46:18 - Mentoring students
    50:54 - Funding
    58:08 - Cookies
    59:41 - What are you most proud of?

  3. #13

  4. #14

  5. #15

  6. #16

  7. #17
    "Sosei Heptares and PharmEnable Enter Technology Collaboration for AI-driven Drug Discovery against Challenging GPCR Target"
    - Collaboration combines Sosei Heptares' leading structure-based drug design platform with PharmEnable's advanced artificial intelligence-enabled and medicinal chemistry technologies

    - Joint drug discovery programme on a challenging GPCR target with key role in neurological diseases

    January 12, 2021

  8. #18

  9. #19

  10. #20

Page 2 of 2 FirstFirst 12

Социальные закладки

Социальные закладки

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •